ACS CAN Supports the Women and Lung Cancer Research and Preventive Services Act of 2025
ACS CAN supports the Women and Lung Cancer Research and Preventive Services Act of 2025 to accelerate progress in reducing mortality from lung cancer.
Breast cancer is the most commonly diagnosed cancer and the second-leading cause of cancer death in women.[i],[ii] In 2024, an estimated 310,720 women and 2,790 men will be diagnosed with invasive breast cancer, and approximately 42,250 women and 530 men are expected to die from the disease.ii Although incidence rates have increased slightly over the past decade, death rates from breast cancer have been consistently declining over the last three decades, largely due to increased screening rates and improved treatment.